AEON Biopharma reported total assets of $5.91M and total liabilities of $21.27M for the quarter ended Jun 2026, down 57.2% year over year. This balance sheet covers 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.99M | 0.66M | 0.50M | 0.17M | 0.01M | 0.03M | 9.75M | 0.46M | 0.44M | 16.20M | 5.16M | 1.56M | 3.44M | 0.54M | 0.01M | 10.45M | 8.44M | 5.93M | 3.01M | 3.43M | ||
| Cash & Current Investments | 0.99M | 0.66M | 0.50M | 0.17M | 0.01M | 0.03M | 9.75M | 0.46M | 0.44M | 16.20M | 5.16M | 1.56M | 3.44M | 0.54M | 0.01M | 10.45M | 8.44M | 5.93M | 3.01M | 3.43M | ||
| Prepaid Assets | 0.39M | 0.36M | 0.34M | 0.35M | 0.24M | 0.14M | 0.09M | 0.09M | 0.15M | 0.73M | 1.06M | 0.94M | 0.58M | 1.83M | 1.58M | 1.88M | 1.82M | 1.49M | 0.39M | 0.56M | ||
| Current Assets | 1.38M | 1.03M | 0.84M | 0.52M | 0.25M | 0.17M | 9.84M | 0.54M | 0.59M | 16.91M | 6.22M | 2.50M | 4.02M | 2.37M | 1.59M | 12.32M | 10.26M | 7.41M | 3.40M | 3.99M | ||
| Non-Current Assets | ||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.43M | 0.36M | 0.33M | 0.31M | 0.28M | 0.26M | 0.24M | 0.22M | 0.20M | 0.18M | 0.16M | 0.12M | ||||||||||
| Long-Term Investments | 276.04M | 276.06M | 276.08M | 276.13M | 276.27M | 277.16M | 279.38M | 21.07M | 21.19M | |||||||||||||
| Other Non-Current Assets | 0.20M | 0.12M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.95M | 0.86M | |||||||
| Non-Current Assets | 276.23M | 276.17M | 276.11M | 276.13M | 276.27M | 277.16M | 0.94M | 21.07M | 21.19M | 0.71M | 0.62M | 0.53M | 1.72M | 1.63M | 1.55M | 1.48M | 1.40M | 1.32M | 2.16M | 1.92M | ||
| Assets | 277.62M | 277.20M | 276.95M | 276.65M | 276.51M | 277.32M | 10.78M | 21.62M | 21.79M | 17.62M | 6.85M | 3.03M | 5.73M | 4.00M | 3.14M | 13.80M | 11.66M | 8.73M | 5.56M | 5.91M | ||
| Liabilities | ||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||
| Accounts Payables | 0.10M | 0.07M | 0.63M | 0.74M | 0.85M | 0.94M | 7.81M | 3.98M | 6.96M | 4.01M | 3.39M | 6.52M | 3.03M | 4.63M | 5.91M | 2.44M | 3.91M | 2.53M | 0.94M | 2.70M | ||
| Notes Payables | 70.87M | 0.15M | 1.00M | |||||||||||||||||||
| Payables | 0.10M | 0.07M | 0.63M | 0.74M | 0.85M | 0.94M | 78.67M | 4.13M | 7.96M | 4.01M | 3.39M | 6.52M | 3.03M | 4.63M | 5.91M | 2.44M | 3.91M | 2.53M | 0.94M | 2.70M | ||
| Other Accumulated Expenses | 0.74M | 0.42M | 0.42M | 2.93M | 3.59M | 4.11M | 3.82M | 3.16M | 3.60M | 2.76M | 3.00M | 2.63M | 1.66M | 1.82M | ||||||||
| Current Taxes | 0.10M | 0.15M | 0.20M | 0.05M | 0.02M | 0.25M | 0.29M | 1.29M | 1.06M | |||||||||||||
| Total Current Liabilities | 0.21M | 0.22M | 0.83M | 0.79M | 0.97M | 1.35M | 82.57M | 5.87M | 9.46M | 14.18M | 13.05M | 15.96M | 10.43M | 10.73M | 14.15M | 8.64M | 9.13M | 8.23M | 6.90M | 7.34M | ||
| Non-Current Liabilities | ||||||||||||||||||||||
| Non-Current Debt | 23.13M | 5.09M | 13.29M | 15.17M | 11.69M | 13.32M | 15.17M | 17.05M | 34.60M | 1.76M | ||||||||||||
| Convertible Debt | 17.50M | 60.43M | 17.50M | 5.09M | 13.29M | 15.17M | 11.69M | 13.32M | 15.17M | 17.05M | 34.60M | 1.76M | ||||||||||
| Preferred Stock Liabilities | 276.00M | 276.00M | 276.00M | 276.00M | 276.08M | 276.90M | 278.49M | 20.99M | 21.19M | |||||||||||||
| Minority Interest | 137.95M | |||||||||||||||||||||
| Operating Leases | 0.24M | 0.05M | 1.26M | 1.20M | 1.15M | 1.08M | 1.02M | 0.96M | 0.89M | 0.76M | ||||||||||||
| Other Non-Current Liabilities | 2.17M | 1.45M | 12.00M | 1.47M | 1.84M | 1.19M | 2.03M | 2.12M | 2.34M | 18.16M | 11.39M | |||||||||||
| Total Non-Current Liabilities | 143.84M | 158.44M | 189.41M | 32.21M | 34.25M | 30.52M | 23.10M | 25.39M | 26.27M | 42.43M | 9.88M | |||||||||||
| Total Liabilities | 300.45M | 294.38M | 500.77M | 290.80M | 504.74M | 514.92M | 281.19M | 308.31M | 305.67M | 146.02M | 159.89M | 201.41M | 33.68M | 36.09M | 31.71M | 25.12M | 27.51M | 28.61M | 60.59M | 21.27M | ||
| Shareholder's Equity | ||||||||||||||||||||||
| Total Debt | 94.00M | 0.15M | 1.00M | 5.09M | 13.29M | 15.17M | 11.69M | 13.32M | 15.17M | 17.05M | 34.60M | 1.76M | ||||||||||
| Common Equity | -22.84M | -17.18M | -223.82M | -14.16M | -228.23M | -237.59M | -270.41M | -286.69M | -283.89M | -128.40M | -153.04M | -198.38M | -27.95M | -32.09M | -28.57M | -11.32M | -15.85M | -19.87M | -55.03M | -15.36M | ||
| Liabilities and Shareholders Equity | 277.62M | 277.20M | 276.95M | 276.65M | 276.51M | 277.32M | 10.78M | 21.62M | 21.79M | 17.62M | 6.85M | 3.03M | 5.73M | 4.00M | 3.14M | 13.80M | 11.66M | 8.73M | 5.56M | 5.91M | ||
| Treasury Shares | -0.02M | |||||||||||||||||||||
| Retained Earnings | -22.87M | -17.21M | -16.96M | -14.19M | -12.40M | -11.58M | -474.84M | -7.35M | -11.49M | -447.40M | -473.60M | -591.62M | -427.51M | -433.70M | -431.60M | -422.50M | -429.14M | -433.70M | -470.82M | -483.80M |
Pull AEON Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=AEON&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "AEON", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=AEON&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();